文献速递产科母胎医学

产科高血压急症治疗延迟的相关因素分析

Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
PubMed 文献 · Am J Obstet Gynecol · 2020-02-15

该回顾性队列研究纳入213例发生产科高血压急症的孕产妇,比较60分钟内接受一线治疗与治疗延迟者的特征。结果显示,初始血压未达严重范围、无子痫前期症状、夜间发病、白人种族、有临产症状及孕周较大与治疗延迟相关。

要点

  • 初始血压未达严重范围者治疗延迟风险高3.2倍。
  • 无子痫前期症状者治疗延迟风险高2.7倍。
  • 夜间发病、白人种族、临产症状及孕周增加亦与延迟相关。

核心结论

  • 初始血压未达严重范围、无子痫前期症状、夜间发病、白人种族、有临产症状及孕周增大是导致产科高血压急症治疗延迟的障碍因素。

研究设计与样本

  • 回顾性队列研究,基于2017年1月至2018年6月单中心学术机构的604例出院诊断或用药记录,最终分析213例发生产科高血压急症的孕产妇。

主要发现

  • 213例中110例(51.6%)治疗延迟,103例(48.4%)在60分钟内接受治疗。
  • 初始血压未达严重范围者延迟治疗比值比为3.24(95%CI 1.85-5.68)。
  • 无子痫前期症状者延迟治疗比值比为2.68(95%CI 1.50-4.80)。
  • 白人种族延迟治疗比值比为1.79(95%CI 1.04-3.08);孕周每增加1周,延迟治疗比值比为1.11(95%CI 1.04-1.19);有临产症状者延迟治疗比值比为2.17(95%CI 1.07-4.41)。

关键数值与推荐

  • 产科高血压急症定义为间隔15分钟确认的收缩压≥160 mm Hg或舒张压≥110 mm Hg。
  • 美国妇产科医师学会推荐急性发作的严重高血压应在60分钟内给予一线治疗(静脉拉贝洛尔、静脉肼屈嗪或口服硝苯地平)。

临床怎么用

  • 针对初始血压未达严重范围、无子痫前期症状、夜间发病、白人种族、有临产症状及孕周较大的患者,应建立质量改进措施以促进及时治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obstetric hypertensive emergency is defined as having systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg, confirmed 15 minutes apart. The American College of Obstetricians and Gynecologists recommends that acute-onset, severe hypertension be treated with first line-therapy (intravenous labetalol, intravenous hydralazine or oral nifedipine) within 60 minutes to reduce risk of maternal morbidity and death. OBJECTIVE: Our objective was to identify barriers that lead to delayed treatment of obstetric hypertensive emergency. STUDY DESIGN: A retrospective cohort study was performed that compared women who were treated appropriately within 60 minutes vs those with delay in first-line therapy. We identified 604 patients with discharge diagnoses of chronic hypertension, gestational hypertension, or preeclampsia using International Classification of Diseases-10 codes and obstetric antihypertensive usage in a pharmacy database at 1 academic institution from January 2017 through June 2018. Of these, 267 women (44.2%) experienced obstetric hypertensive emergency in the intrapartum period or within 2 days of delivery; the results from 213 women were used for analysis. We evaluated maternal characteristics, presenting symptoms and circumstances, timing of hypertensive emergency, gestational age at presentation, and administered medications. Chi square, Fisher's exact, Wilcoxon rank-sum, and sample t-tests were used to compare the 2 groups. Univariable logistic regression was applied to determine predictors of delayed treatment. Multivariable regression model was also performed; C-statistic and Hosmer and Lemeshow goodness-of-fit test were used to assess the model fit. A result was considered statistically significant at P<.05. RESULTS: Of the 213 women, 110 (51.6%) had delayed treatment vs 103 (48.4%) who were treated within 60 minutes. Patients who had delayed treatment were 3.2 times more likely to have an initial blood pressure in the nonsevere range vs those who had timely treatment (odds ratio, 3.24; 95% confidence interval, 1.85-5.68). Timeliness of treatment was associated with presence or absence of preeclampsia symptoms; patients without preeclampsia symptoms were 2.7 times more likely to have delayed treatment (odds ratio, 2.68; 95% confidence interval, 1.50-4.80). Patients with hypertensive emergencies that occurred overnight between 10 pm and 6 am were 2.7 times more likely to have delayed treatment vs those emergencies that occurred between 6 am and 10 pm (odds ratio, 2.72; 95% confidence interval, 1.27-5.83). Delayed treatment also had an association with race, with white patients being 1.8 times more likely to have delayed treatment (odds ratio, 1.79; 95% confidence interval, 1.04-3.08). Patients who were treated at <60 minutes had a lower gestational age at presentation vs those with delayed treatment (34.6±5 vs 36.6±4 weeks, respectively; P<.001). For every 1-week increase in gestational age at presentation, there was a 9% increase in the likelihood of delayed treatment (odds ratio, 1.11; 95% confidence interval, 1.04-1.19). Another factor that was associated with delay of treatment was having a complaint of labor symptoms, which made patients 2.2 times as likely to experience treatment delay (odds ratio, 2.17; 95% confidence interval, 1.07-4.41). CONCLUSION: Initial blood pressure in the nonsevere range, absence of preeclampsia symptoms, presentation overnight, white race, having complaint of labor symptoms, and increasing gestational age at presentation are barriers that lead to a delay in the treatment of obstetric hypertensive emergency. Quality improvement initiatives that target these barriers should be instituted to improve timely treatment.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kantorowska A, Heiselman CJ, Halpern TA, et al. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies. Am J Obstet Gynecol. 2020. PMID: 32067968. doi:10.1016/j.ajog.2020.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。